Profitability Ratios
| Ratio |
Value |
| GP Margin |
46.4% |
| EBIT Margin |
11.8% |
| EBITDA Margin |
19.2% |
| Operating Margin |
11.8% |
| Pretax Margin |
-14.5% |
| Cont. Ops Margin |
-21.4% |
| Net Margin |
-21.4% |
| Bottom Line Margin |
-21.4% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.59 |
| Quick Ratio |
2.59 |
| Solvency Ratio |
-0.099 |
| Cash Ratio |
0.91 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.03 |
| Forward PEG |
-0.03 |
| Price/Book |
1.23 |
| Price/Sales |
0.63 |
| Price/FCF |
10.90 |
| Price/Op Cash Flow |
5.65 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.4879 |
| Debt/Equity |
1.7159 |
| Debt/Capital |
0.6318 |
| Long-Term Debt/Capital |
0.5506 |
| Financial Leverage |
3.52 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
3.72 |
| Operating Cash Flow Ratio |
0.742 |
| Operating Cash Flow/Sales |
11.1% |
| Free Cash Flow/Operating Cash Flow |
51.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.28 |
| Interest Coverage |
1.3702 |
| Short-Term Operating Cash Flow Coverage |
9.91 |
| Operating Cash Flow Coverage |
0.13 |
| Capital Expenditure Coverage |
2.07 |
| Dividend + Capital Expenditure Coverage |
2.07 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
1.96 |
| EPS |
-0.418 |
| Debt/Share |
1.8807 |
| Cash/Share |
0.27 |
| Book Value/Share |
0.74 |
| Tangible BV/Share |
-0.68 |
| Equity/Share |
1.00 |
| Operating Cash Flow/Share |
0.218 |
| Capital Expenditure/Share |
0.105 |
| FCF/Share |
0.113 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.468 |
| Earnings Before Tax/EBIT |
-1.237 |
| Price/Fair Value |
1.23 |
| Debt/Market Cap |
1.0120 |
| Effective Tax Rate |
-46.8% |
| Enterprise Value Multiple |
7.12 |
CRLBF - Cresco Labs Inc.